Presynaptic dopaminergic function in the striatum of schizophrenic patients

被引:119
作者
DaoCastellana, MH
PaillereMartinot, ML
Hantraye, P
AttarLevy, D
Remy, P
Crouzel, C
Artiges, E
Feline, A
Syrota, A
Martinot, JL
机构
[1] CEA,SERV HOSP FREDERIC JOLIOT,INSERM,U334,F-91406 ORSAY,FRANCE
[2] CNRS,URA 1285,F-91405 ORSAY,FRANCE
[3] HOP BICETRE,LE KREMLIN BICETR,FRANCE
[4] HOP A CHENEVIER,CRETE,NE
[5] ASSOC SANTE MENTALE 13EME ARRONDISSEMENT,PARIS,FRANCE
关键词
dopamine; PET; schizophrenia; F-18-DOPA;
D O I
10.1016/S0920-9964(96)00102-8
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The dopaminergic hypothesis of schizophrenia postulates increased brain dopaminergic activity. Two previous studies reported increased F-18-DOPA uptake with positron emission tomography in schizophrenic patients (n=5, n=7). In the present study, striatal dopaminergic function was assessed in vivo in six untreated schizophrenics and seven control subjects, comparable for age and sex. The F-18-fluoro-L-DOPA (F-18-DOPA) uptake rate constant K-i was determined in the caudate and putamen using coregistered positron emission tomography and magnetic resonance imaging. No difference between groups for mean K-i was found. The variability of the F-18-DOPA uptake values was higher in the caudate (p<0.01) and in the putamen (p<0.001) in schizophrenic patients than in control subjects, suggesting that schizophrenia is a disorder involving heterogeneous states of the striatal presynaptic dopaminergic function.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 39 条
[31]  
PICKAR D, 1986, ARCH GEN PSYCHIAT, V43, P669
[32]   ELEVATED DOPA DECARBOXYLASE ACTIVITY IN LIVING BRAIN OF PATIENTS WITH PSYCHOSIS [J].
REITH, J ;
BENKELFAT, C ;
SHERWIN, A ;
YASUHARA, Y ;
KUWABARA, H ;
ANDERMANN, F ;
BACHNEFF, S ;
CUMMING, P ;
DIKSIC, M ;
DYVE, SE ;
ETIENNE, P ;
EVANS, AC ;
LAL, S ;
SHEVELL, M ;
SAVARD, G ;
WONG, DF ;
CHOUINARD, G ;
GJEDDE, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11651-11654
[33]  
REITH J, 1990, SOC NEUR ABSTR, V1, P166
[34]   CLINICAL CORRELATES OF [F-18]FLUORODOPA UPTAKE IN 5 GRAFTED PARKINSONIAN-PATIENTS [J].
REMY, P ;
SAMSON, Y ;
HANTRAYE, P ;
FONTAINE, A ;
DEFER, G ;
MANGIN, JF ;
FENELON, G ;
GENY, C ;
RICOLFI, F ;
FROUIN, V ;
NGUYEN, JP ;
JENY, R ;
DEGOS, JD ;
PESCHANSKI, M ;
CESARO, P .
ANNALS OF NEUROLOGY, 1995, 38 (04) :580-588
[35]   BEYOND THE DOPAMINE HYPOTHESIS - THE NEUROCHEMICAL PATHOLOGY OF SCHIZOPHRENIA [J].
REYNOLDS, GP .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 155 :305-316
[36]  
ROGERS D, 1990, J NEUROPSYCHIAT, V3, P334
[37]   SEPARATING PARKINSONS-DISEASE FROM NORMALITY - DISCRIMINANT FUNCTION-ANALYSIS OF FLUORODOPA F-18 POSITRON EMISSION TOMOGRAPHY DATA [J].
SAWLE, GV ;
PLAYFORD, ED ;
BURN, DJ ;
CUNNINGHAM, VJ ;
BROOKS, DJ .
ARCHIVES OF NEUROLOGY, 1994, 51 (03) :237-243
[38]   HUMAN POSITRON EMISSION TOMOGRAPHIC [F-18] FLUORODOPA STUDIES CORRELATE WITH DOPAMINE CELL COUNTS AND LEVELS [J].
SNOW, BJ ;
TOOYAMA, I ;
MCGEER, EG ;
YAMADA, T ;
CALNE, DB ;
TAKAHASHI, H ;
KIMURA, H .
ANNALS OF NEUROLOGY, 1993, 34 (03) :324-330
[39]   POSITRON EMISSION TOMOGRAPHY REVEALS ELEVATED D2 DOPAMINE-RECEPTORS IN DRUG-NAIVE SCHIZOPHRENICS [J].
WONG, DF ;
WAGNER, HN ;
TUNE, LE ;
DANNALS, RF ;
PEARLSON, GD ;
LINKS, JM ;
TAMMINGA, CA ;
BROUSSOLLE, EP ;
RAVERT, HT ;
WILSON, AA ;
TOUNG, JKT ;
MALAT, J ;
WILLIAMS, JA ;
OTUAMA, LA ;
SNYDER, SH ;
KUHAR, MJ ;
GJEDDE, A .
SCIENCE, 1986, 234 (4783) :1558-1563